Publication | Closed Access

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Hematological MalignancyBone Marrow FailureMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood DisorderHematologyImmunologyPathologyAutoimmunityImmunotherapyMedicineImmunophenotypic BiomarkerMyeloid Neoplasia